Remedy Pharmaceuticals, Inc. — Form D

Remedy Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-04. The offering totals $9.1M, of which $9.1M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2015-12-04
Form: D
Accession: 0001501657-15-000002
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $9.1M
Amount sold: $9.1M
Investors: 30
Date of first sale: 2015-11-16
Security types: equity, debt
Revenue range: Decline to Disclose
SEC file number: 021-252449

Issuer

Name: Remedy Pharmaceuticals, Inc.
CIK: 0001501657
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 122 WEST 27TH STREET, NEW YORK, NY, 10001
Phone: 212-586-2226

Officers, directors & promoters (5)

Name	Role	Location
DAVID GELIEBTER	Director	NEW YORK, NY
SVEN JACOBSON	Director	NEW YORK, NY
SVEN JACOBSON	Executive Officer	NEW YORK, NY
DAVID M GELIEBTER	Director	NEW YORK, NY
DAVID M. GELIEBTER	Director	NEW YORK, NY

Other filings by this issuer (7)

Filed	Form	Offering	Sold
2014-02-26	D	$1.4M	$1.0M
2012-07-06	D/A	$4.1M	$4.1M
2012-05-22	D	$2.7M	$2.7M
2012-03-06	D/A	$793K	$793K
2011-11-22	D/A	$500K	$500K
2011-10-19	D	$250K	$250K
2010-09-22	D	$400K	$400K

More